Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine.
from News Medical Medical Research News Feed https://ift.tt/nQByGXS
0 Comments